Table 2.
Body composition and inflammatory indexes according to myosteatosis of esophageal cancer patients
| Parameter | All‐patients (n = 123) | No‐myosteatosis (n = 51) | Myosteatosis (n = 72) | P value |
|---|---|---|---|---|
| Skeletal muscle, mean (SD) | ||||
| Area (cm2) | 122.1 (24.5) | 118.0 (27.2) | 125.0 (22.0) | .12 |
| Mean MA (HU) | 38.8 (9.3) | 47.1 (6.4) | 32.9 (5.7) | <.01 |
| SMI (cm2/m2) | 44.7 (8.4) | 43.2 (9.3) | 45.7 (7.7) | .10 |
| Sarcopenia, no (%) | 57 (46.3) | 24 (47.1) | 33 (45.8) | .89 |
| Adipose tissue, median (IQR) | ||||
| Visceral, area (cm2) | 25.1 (6.7‐102.0) | 8.4 (1.3‐21.5) | 65.9 (21.5‐135.2) | <.01 |
| VFI (cm2/m2) | 8.6 (2.3‐38.3) | 2.9 (0.6‐7.9) | 25.4 (7.7‐52.3) | <.01 |
| Subcutaneous, area (cm2) | 40.9 (13.6‐75.3) | 19.0 (0.9‐48.3) | 52.7 (29.0‐104.0) | <.01 |
| SFI (cm2/m2) | 15.1 (4.6‐28.7) | 6.9 (0.4‐17.9) | 19.1 (10.5‐38.1) | <.01 |
| Intramuscular, area (cm2) | 6.6 (2.9‐11.2) | 2.9 (1.9‐6.5) | 9.3 (5.7‐12.7) | <.01 |
| Inflammatory indexes | ||||
| NLR, median (IQR) | 2.8 (2.3) | 3.8 (3.0) | 2.6 (1.9) | <.01 |
| PLR, median (IQR) | 133.1 (81.7) | 153.7 (71.0) | 118.4 (76.0) | <.01 |
Abbreviations: HU, Hounsfield units; IQR, interquartile range; MA, muscle attenuation; NLR, neutrophil‐to‐lymphocyte ratio; SD, standard deviation; SFI, subcutaneous fat index; SMI, skeletal muscle index; VFI, visceral fat index.